Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis

Amyotrophic lateral sclerosis (ALS) is a clinically highly heterogeneous disease with a survival rate ranging from months to decades. Evidence suggests that a systemic deregulation of immune response may play a role and affect disease progression. Here, we measured 62 different immune/metabolic medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Picher-Martel, Vincent, Boutej, Hejer, Vézina, Alexandre, Cordeau, Pierre, Kaneb, Hannah, Julien, Jean-Pierre, Genge, Angela, Dupré, Nicolas, Kriz, Jasna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049559/
https://www.ncbi.nlm.nih.gov/pubmed/36982140
http://dx.doi.org/10.3390/ijms24065065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049559/
https://www.ncbi.nlm.nih.gov/pubmed/36982140
http://dx.doi.org/10.3390/ijms24065065

Ejemplares similares